In addition, annual estimates of RSV-associated ICU admissions ranged from 24,400 to 34,900 for the 2016-2017 and 2017-2018 ...
The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...
Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can ...
especially in indoor spaces These respiratory droplets and aerosols are created when an infected person: COVID-19 can also spread by touching something that has the virus on it, then touching your ...
In August 2023, BD received FDA clearance for its BD Respiratory Viral Panel (RVP) for the BD MAXTM System. This innovative single molecular diagnostic combination test swiftly identified and ...